Incidence, Associated Factors, and Burden of Post COVID-19 Condition in Brazil
Inova Medical
1,694 participants
Jul 21, 2023
OBSERVATIONAL
Conditions
Summary
This is a national retrospective cohort study with internet-based recruitment which intends to enroll 1,694 adult patients with COVID-19 diagnosis during the SARS-CoV-2 omicron wave in Brazil. Participants with confirmed symptomatic COVID-19 after january 2022 will be evaluated in order to assess incidence, potential risk factors and impact of post COVID-19 condition according to the WHO definition on health-related quality of life and other relevant patient-centered outcomes.
Eligibility
Inclusion Criteria3
- Age ≥ 18 years;
- Brazilian resident;
- Symptomatica COVID-19 confirmed by reverse transcriptase polymerase chain reaction (RT-PCR) or antigen test for SARS-COV-2 after January 2022, with diagnosis at least 90 days before recruitment.
Exclusion Criteria3
- No availability to participate in remote research appointments;
- Communication difficulty (aphasia, important hearing loss, non-portuguese speaker, severe dementia)
- Refuse to provide informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Exposures variables (observational study): age, gender, education, comorbidities, vaccination status, severity of the acute episode of COVID-19, treatments used for acute COVID-19.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05822193